Detected ·

Inocras Inc.

$31M—

Inocras Inc., a whole-genome sequencing and bioinformatics company for oncology, raised $31M in an oversubscribed Series B-3, bringing total funding to ~$100M. The new capital will support building U.S. commercial and operational infrastructure from San Diego.

Amount
$31 000 000 USD
Stage
—
Event
Funding round
Detected
2026-08-04 16:03:43 UTC
Signal ID
cc2f2970-b5a8-4b6c-8dfe-2765c1b02e44

As the API returns it

{
  "id": "cc2f2970-b5a8-4b6c-8dfe-2765c1b02e44",
  "created_at": "2026-08-04T16:03:43.484389Z",
  "company_name": "Inocras Inc.",
  "company_website_url": "inocras.com",
  "company_linkedin_url": "https://www.linkedin.com/company/inocras-inc",
  "event_type": "funding",
  "funding_amount": 31000000,
  "funding_currency": "USD",
  "funding_stage": null,
  "message": "*Inocras Inc., a whole-genome sequencing and bioinformatics company for oncology, raised $31M in an oversubscribed Series B-3, bringing total funding to ~$100M. The new capital will support building U.S. commercial and operational infrastructure from San Diego.*"
}